A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10ng/ml…

Overview of attention for article published in European Urology, September 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 10 news outlets
twitter: 11 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 201 Dimensions

Readers on

mendeley: 168 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 12 X posts from 11 X users, with an upper bound of 59,231 followers.

Exosomes obtained from urine samples offer potential as prostate cancer biomarkers to distinguish high-grade from low-grade prostate cancer, thus clarifying PSA test results before biopsy. https://t.co/rDsvqlIN2O

09 Feb 2024

Reply Repost Favourite

@dr_coops @daviesbj @rhankb @GoldbergHanan btw... what about @ExosomeDx? @UCSFUrology data after all... https://t.co/IdBho0YaMA

19 Oct 2019

Reply Repost Favourite

RT @EUplatinum: This represents a second prospective validation of a novel, urine-exosome gene expression to predict high grade PCA: https:…

11 Dec 2018

Reply Repost Favourite

RT @EUplatinum: This represents a second prospective validation of a novel, urine-exosome gene expression to predict high grade PCA: https:…

10 Dec 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.